Effect of adding selegiline to levodopa in early, mild Parkinson's disease. Formal systematic review of data on patients in all relevant trials is required.

This publication has 7 references indexed in Scilit:

• Effect of selegiline on mortality in patients with Parkinson's disease
  Neurology, 1998
• Investigation by Parkinson's Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson's disease: further results of randomised trial and confidential inquiry
  BMJ, 1998
• Mortality in DATATOP: A Multicenter trial in early Parkinson's disease
  Annals of Neurology, 1998
• Selegiline as the primary treatment of Parkinson's disease - a long-term double-blind study
  Acta Neurologica Scandinavica, 1997
• The effects of early selegiline therapy on long‐term levodopa treatment and parkinsonian disability: An interim analysis of a norwegian–danish 5‐year study
  Movement Disorders, 1997
• Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Other studies have not shown increased mortality.
  1996
• Increased life expectancy resulting from addition of l-deprenyl to Madopar® treatment in Parkinson's disease: A longterm study
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985